Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
about
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Endocrine and haemodynamic cha ...... THWAY-2 mechanisms substudies.
@en
Endocrine and haemodynamic cha ...... THWAY-2 mechanisms substudies.
@nl
type
label
Endocrine and haemodynamic cha ...... THWAY-2 mechanisms substudies.
@en
Endocrine and haemodynamic cha ...... THWAY-2 mechanisms substudies.
@nl
prefLabel
Endocrine and haemodynamic cha ...... THWAY-2 mechanisms substudies.
@en
Endocrine and haemodynamic cha ...... THWAY-2 mechanisms substudies.
@nl
P2093
P2860
P50
P1476
Endocrine and haemodynamic cha ...... ATHWAY-2 mechanisms substudies
@en
P2093
British Hypertension Society p ...... Therapy (PATHWAY) Study Group
Bryan Williams
David J Webb
Gordon T McInnes
J Kennedy Cruickshank
Jackie Salsbury
Morris J Brown
Peter Sever
Steve V Morant
P2860
P304
P356
10.1016/S2213-8587(18)30071-8
P577
2018-04-11T00:00:00Z